Decreased regional cerebral metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms

被引:29
作者
Komatsu, N
Kodama, K
Yamanouchi, N
Okada, S
Noda, S
Nawata, Y
Takabayashi, K
Iwamoto, I
Saito, Y
Uchida, Y
Ito, H
Yoshikawa, K
Sato, T
机构
[1] Chiba Univ, Sch Med, Dept Neuropsychiat, Chuo Ku, Chiba 2608677, Japan
[2] Chiba Univ, Sch Med, Dept Internal Med 2, Chiba 2608677, Japan
[3] Chiba Univ, Sch Med, Dept Radiol, Chiba 2608677, Japan
[4] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Div Radiat Med, Chiba 260, Japan
关键词
systemic lupus erythematosus; psychiatric symptom; positron emission tomography; regional cerebral metabolic rate for glucose attentional deficits;
D O I
10.1159/000008067
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To determine brain functional abnormality in systemic lupus erythematosus (SLE) patients with psychiatric symptoms, we evaluated 12 active SLE patients with or without psychiatric symptoms by means of [F-18]2-fluoro-2-deoxy-D-glucose positron emission tomography (PET), magnetic resonance imaging and neuropsychological testing. Patients with psychiatric symptoms showed significantly poorer performance in tests which subserved attentional function. The PET study revealed that the psychiatric patients had significantly decreased regional cerebral metabolic rates for glucose in the prefrontal, inferior parietal and anterior cingulate regions. Prefrontal, inferior parietal and anterior cingulate dysfunction may be related to attentional deficits that are involved in various psychiatric symptoms in SLE. PET is an invaluable tool to reveal such brain functional abnormality seen in SLE patients with psychiatric symptoms.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 37 条
[1]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[2]   CEREBROVASCULAR-DISEASE AND ANTIPHOSPHOLIPID ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS, LUPUS-LIKE DISEASE, AND THE PRIMARY ANTIPHOSPHOLIPID SYNDROME [J].
ASHERSON, RA ;
KHAMASHTA, MA ;
GIL, A ;
VAZQUEZ, JJ ;
CHAN, O ;
BAGULEY, E ;
HUGHES, GRV .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04) :391-399
[3]   CHOROID-PLEXUS IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ATKINS, CJ ;
QUISMORIO, FP ;
FRIOU, GJ ;
KONDON, JJ .
ANNALS OF INTERNAL MEDICINE, 1972, 76 (01) :65-+
[4]   CEREBRAL BLOOD-FLOW IN SYSTEMIC LUPUS-ERYTHEMATOSUS WITH AND WITHOUT CENTRAL NERVOUS-SYSTEM INVOLVEMENT [J].
AWADA, HH ;
MAMO, HL ;
LUFT, AG ;
PONSIN, JC ;
KAHN, MF .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (12) :1597-1601
[5]  
Benton A.L., 1994, Contributions to neuropsychological assessment, V2nd
[6]   CEREBROSPINAL-FLUID ANTIBODIES TO NEURONAL CELLS - ASSOCIATION WITH NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLUESTEIN, HG ;
WILLIAMS, GW ;
STEINBERG, AD .
AMERICAN JOURNAL OF MEDICINE, 1981, 70 (02) :240-246
[7]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[8]   ASSOCIATION BETWEEN LUPUS PSYCHOSIS AND ANTI-RIBOSOMAL P PROTEIN ANTIBODIES [J].
BONFA, E ;
GOLOMBEK, SJ ;
KAUFMAN, LD ;
SKELLY, S ;
WEISSBACH, H ;
BROT, N ;
ELKON, KB .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :265-271
[9]   NEUROPSYCHIATRIC DISORDER IN SYSTEMIC LUPUS-ERYTHEMATOSUS - EVIDENCE FOR BOTH VASCULAR AND IMMUNE-MECHANISMS [J].
BRESNIHAN, B ;
HOHMEISTER, R ;
CUTTING, J ;
TRAVERS, RL ;
WALDBURGER, M ;
BLACK, C ;
JONES, T ;
HUGHES, GRV .
ANNALS OF THE RHEUMATIC DISEASES, 1979, 38 (04) :301-306
[10]  
BROOKS RA, 1982, J NUCL MED, V23, P538